Offering Circular | Selected Risks Related to this Offering | TruBrain's SEC EDGAR Page

For more information on TriplePulse, Inc. (TruBrain), download and review the Offering Circular. The Offering Circular should be reviewed before making an investment decision.

.......

Anxiety is the enemy of cognitive health 

.....

......

..........

Demand for anxiety treatments is growing

Anxiety is crippling to the cognitive health of nearly 125M Americans. And that number is growing. The World Health Organization estimates that since 2020, the amount of people suffering with anxiety has increased 25% worldwide. 

Large hardware technology firms often avoid the medical device category due to the compliance and scientific expertise required, leaving an opportunity for more nimble, specialized brands like TruBrain to build market share.

Wearable Tech for Anxiety

Our team has spent considerable time validating our path to market. We believe that it is optimal for us to start as a Class II medical device for anxiety, versus Class III for depression. This allows us to save considerable time, money, and risk of Cranial Electrotherapy Stimulators achieving FDA Class III status.

.......

.......

.......

Customers 🖤 TruBrain

TruBrain customers come from all walks of life and work in nearly every profession. Members of the armed forces order TruBrain to more than 70 bases around the globe. Parents take TruBrain after a long day of work so they’ll still have energy to read to their kids and help them with their homework. Writers, producers, and artists swear by TruBrain to boost their creative process. Our customers live in over 80 countries around the world. We work to offer compelling, proactive, healthy alternatives to low-performance packaged foods and over-stimulating pharmaceuticals.

*These testimonials may not be representative of the experience of other customers and are not a guarantee of future performance or success

In the Press

*These testimonials may not be representative of the experience of other customers and are not a guarantee of future performance or success

We read minds. Literally.

At TruBrain, our focus is human performance, and our products are designed to enhance your brain's natural abilities. We bring high-performance food and beverage nutrition that delivers positive, measurable outcomes to mainstream consumers.  Brainwave measurement is at the core of our origin as a company. We never claimed to be the smartest people on the planet, but we know some of the people who are – artists, surgeons, CEOs, and musicians. So we picked their brains, literally. We studied their thought patterns, their ability to handle stress, how they thought on their feet, and how they dealt with distractions. This led to the understanding of optimal brainwave patterns and the beginning of our journey to help people find their true brain.

Consumer execs & neuroscience nerds

We’re led by a visionary founder and veteran leadership with wide experience in neuroscience, healthcare, & consumer experience. Our CEO, Chris Thompson, has deep industry experience in consumer packaged goods - he managed billion dollar brands for Unilever, one of the largest CPG companies in the world. We use what we sell. Whether it is Chris testing Ketones during endurance training or Dr. Andrew Hill testing the latest neurotechnology in the EEG brain lab - we take it, we test it, we share it, we improve it. We have fostered a team whose collective efforts are all driven toward elevating the lives of our customers. Our purpose is to empower people to do their best thinking.

Our Investors

Expand with us

Our customers asked us to work on a large barrier in their way of performance - anxiety. We are so excited to attack the anxiety market with our wearable technology by top neuroscientists. We believe this will offer a compelling alternative to pharmaceuticals that have many side effects and will further our reach and status as the leading brand in cognitive healthcare.

Our mission is to make high function solutions accessible to mainstream consumers. Our products deliver a material benefit in people’s lives, and our role is to help them access these benefits. We believe the direct relationship with consumers is the most valuable component in the cognitive healthcare system, and we work to offer compelling, proactive health alternatives to low-function packaged goods and overly stimulating pharmaceuticals. 

The expansion of our product portfolio to include wearables, and the ability to offer a personalized healthcare experience only furthers our standing as one of the leading brands in the space. We think that through our brand equity, technology, extensive press coverage, and market timing, we will scale to widespread acceptance.

Join us and say hello to your TruBrain.

Chris Thompson, CEO

Footnotes

[1] - https://www.globenewswire.com/news-release/2019/01/11/1690384/0/en/Global-Nootropics-Market-Will-Reach-USD-5-959-Million-By-2024-Zion-Market-Research.html

[2] - https://www.prnewswire.com/news-releases/the-global-ketogenic-diet-food-market-is-forecasted-to-reach-usd-12-35-billion-in-2024--at-an-estimated-cagr-of-5-3-300879801.html

[3] - https://bit.ly/36efVUe

[4] - https://www.nytimes.com/2004/10/12/business/company-news-abbott-to-acquire-eas-for-320-million.html

[5] - https://www.forbes.com/sites/elanagross/2020/08/31/bayer-agrees-to-buy-personalized-vitamin-company-careof-at-225-million-valuation/?sh=56d6b0c4398d

[6] - https://www.prnewswire.com/news-releases/kellogg-adds-rxbar-fastest-growing-us-nutrition-bar-brand-to-wholesome-snacks-portfolio-300532438.html

[7] - https://www.bloomberg.com/news/articles/2020-10-01/hims-inks-1-6-billion-deal-to-go-public-via-oaktree-spac

[8] - https://www.cnbc.com/2019/05/10/why-amazon-bought-pillpack-for-753-million-and-what-happens-next.html

[9] - https://www.foodbusinessnews.net/articles/11026-hershey-to-acquire-amplify-snack-brands-for-1-6-billion

[10] - https://pubmed.ncbi.nlm.nih.gov/30597564/

[11] - https://www.businessnewsdaily.com/5658-easy-productivity-tips.html#the-negative-impact-of-multitasking

[12] - https://www.sciencedaily.com/releases/2018/07/180710104631.htm

---

AN OFFERING STATEMENT REGARDING THIS OFFERING HAS BEEN FILED WITH THE SEC. THE SEC HAS QUALIFIED THAT OFFERING STATEMENT, WHICH ONLY MEANS THAT THE COMPANY MAY MAKE SALES OF THE SECURITIES DESCRIBED BY THE OFFERING STATEMENT. IT DOES NOT MEAN THAT THE SEC HAS APPROVED, PASSED UPON THE MERITS OR PASSED UPON THE ACCURACY OR COMPLETENESS OF THE INFORMATION IN THE OFFERING STATEMENT.

THE OFFERING CIRCULAR THAT IS PART OF THAT OFFERING STATEMENT CAN BE FOUND HERE.

THE OFFERING MATERIALS MAY CONTAIN FORWARD-LOOKING STATEMENTS AND INFORMATION RELATING TO, AMONG OTHER THINGS, THE COMPANY, ITS BUSINESS PLAN AND STRATEGY, AND ITS INDUSTRY. THESE FORWARD-LOOKING STATEMENTS ARE BASED ON THE BELIEFS OF, ASSUMPTIONS MADE BY, AND INFORMATION CURRENTLY AVAILABLE TO THE COMPANY’S MANAGEMENT. WHEN USED IN THE OFFERING MATERIALS, THE WORDS “ESTIMATE,” “PROJECT,” “BELIEVE,” “ANTICIPATE,” “INTEND,” “EXPECT” AND SIMILAR EXPRESSIONS ARE INTENDED TO IDENTIFY FORWARD-LOOKING STATEMENTS, WHICH CONSTITUTE FORWARD LOOKING STATEMENTS. THESE STATEMENTS REFLECT MANAGEMENT’S CURRENT VIEWS WITH RESPECT TO FUTURE EVENTS AND ARE SUBJECT TO RISKS AND UNCERTAINTIES THAT COULD CAUSE THE COMPANY’S ACTUAL RESULTS TO DIFFER MATERIALLY FROM THOSE CONTAINED IN THE FORWARD-LOOKING STATEMENTS. INVESTORS ARE CAUTIONED NOT TO PLACE UNDUE RELIANCE ON THESE FORWARD-LOOKING STATEMENTS, WHICH SPEAK ONLY AS OF THE DATE ON WHICH THEY ARE MADE. THE COMPANY DOES NOT UNDERTAKE ANY OBLIGATION TO REVISE OR UPDATE THESE FORWARD-LOOKING STATEMENTS TO REFLECT EVENTS OR CIRCUMSTANCES AFTER SUCH DATE OR TO REFLECT THE OCCURRENCE OF UNANTICIPATED EVENTS.

WHILE THE COMPANY HAS SIGNED A QUOTATION AGREEMENT TO TRADE THE SECURITIES OFFERED ON STARTENGINE SECONDARY’S NEW ALTERNATIVE TRADING SYSTEM (THE “ATS”), A COMPANY WHICH INTENDS TO BE QUOTED ON THE MARKETPLACE WILL BE SUBJECT TO CERTAIN REQUIREMENTS WHICH THE COMPANY MAY OR MAY NOT BE ABLE TO SATISFY IN A TIMELY MANNER. EVEN IF A COMPANY IS QUALIFIED TO QUOTE ITS SECURITIES ON THE MARKET, THERE IS NO GUARANTEE AN ACTIVE TRADING MARKET FOR THE SECURITIES WILL EVER DEVELOP, OR IF DEVELOPED, BE MAINTAINED.  YOU SHOULD ASSUME THAT YOU MAY NOT BE ABLE TO LIQUIDATE YOUR INVESTMENT FOR SOME TIME OR BE ABLE TO PLEDGE THESE SHARES AS COLLATERAL.

TruBrain 17b Disclosure